• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂(t-PA)的分子生物学及重组t-PA的临床应用

[Molecular biology of tissue-type plasminogen activator (t-PA) and clinical application of recombinant t-PA].

作者信息

Fukao H, Matsuo O

机构信息

Department of Physiology, Kinki University School of Medicine.

出版信息

Nihon Rinsho. 1993 Jun;51(6):1620-6.

PMID:8320841
Abstract

Activation of blood fibrinolysis is initiated by the activation of plasminogen to plasmin by plasminogen activator (PA). The plasmin thus produced can degrade fibrin, the main component of thrombus. Tissue-type PA (t-PA) which is mainly secreted from vascular endothelial cells possesses a high affinity for fibrin in contrast to urokinase-type PA (u-PA). Enzymatic activity of t-PA is expressed in either single-chain form or two-chain form. Further, t-PA activity enhanced markedly in the presence of fibrin; 600-1,000-fold increase. Thus, the thrombolytic therapy is now being performed by using t-PA. The mechanism for thrombolysis by t-PA involves the activation of fibrinolytic system on the fibrin surface. The kringle 2 domain of t-PA molecule plays an important role on the binding to fibrin. But in single-chain t-PA, finger domain plays a role for its binding to fibrin. Recent studies have revealed that the t-PA specific receptor (t-PAR) is expressed on the endothelial cells which localizes t-PA activity by fixing t-PA around the cells.

摘要

血液纤维蛋白溶解的激活是由纤溶酶原激活剂(PA)将纤溶酶原激活为纤溶酶引发的。由此产生的纤溶酶可降解血栓的主要成分纤维蛋白。与尿激酶型纤溶酶原激活剂(u-PA)相比,主要由血管内皮细胞分泌的组织型纤溶酶原激活剂(t-PA)对纤维蛋白具有高亲和力。t-PA的酶活性以单链形式或双链形式表达。此外,在纤维蛋白存在的情况下,t-PA活性显著增强;增加600 - 1000倍。因此,现在正在使用t-PA进行溶栓治疗。t-PA溶栓的机制涉及纤维蛋白表面纤溶系统的激活。t-PA分子的kringle 2结构域在与纤维蛋白的结合中起重要作用。但在单链t-PA中,指状结构域在其与纤维蛋白的结合中起作用。最近的研究表明,t-PA特异性受体(t-PAR)在内皮细胞上表达,通过将t-PA固定在细胞周围来定位t-PA活性。

相似文献

1
[Molecular biology of tissue-type plasminogen activator (t-PA) and clinical application of recombinant t-PA].组织型纤溶酶原激活剂(t-PA)的分子生物学及重组t-PA的临床应用
Nihon Rinsho. 1993 Jun;51(6):1620-6.
2
Fibrin-specific thrombolytic agents.纤维蛋白特异性溶栓剂。
Klin Wochenschr. 1988;66 Suppl 12:15-23.
3
Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.与纤维蛋白结合的1型纤溶酶原激活物抑制剂(PAI-1)与组织型纤溶酶原激活物(t-PA)或尿激酶型纤溶酶原激活物(u-PA)之间的相互作用。t-PA的指状结构域和kringle-2结构域介导t-PA/PAI-1复合物与纤维蛋白的结合。
J Clin Invest. 1989 Aug;84(2):647-55. doi: 10.1172/JCI114211.
4
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
5
Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.纤维蛋白溶解的分子机制及其在纤维蛋白特异性溶栓治疗中的应用。
J Cell Biochem. 1987 Feb;33(2):77-86. doi: 10.1002/jcb.240330202.
6
Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).组织型纤溶酶原激活剂与尿激酶型纤溶酶原激活剂重组嵌合体(rt-PA/u-PA)的结构域缺失和/或重复突变体的特性分析
Thromb Haemost. 1990 Aug 13;64(1):53-60.
7
[Mechanism of thrombolytic enzymes].
Rinsho Ketsueki. 1993 Apr;34(4):395-402.
8
Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.通过在纤溶酶切割位点融合获得的嵌合型(组织型/尿激酶型)纤溶酶原激活剂的特性。
Thromb Haemost. 1993 May 3;69(5):466-72.
9
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.重组双链人组织型纤溶酶原激活剂催化结构域的2.3埃晶体结构。
J Mol Biol. 1996 Apr 26;258(1):117-35. doi: 10.1006/jmbi.1996.0238.
10
Characterization of human tissue-type plasminogen activator variants with amino acid mutations in the kringle 1 domain.对kringle 1结构域存在氨基酸突变的人组织型纤溶酶原激活剂变体的表征
Blood Coagul Fibrinolysis. 1992 Aug;3(4):381-7.